Illumina, Inc.
ILMN Healthcare Diagnostics & Research
Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow ILMN
Illumina, Inc. (ILMN) Operating cash flow
Illumina, Inc.'s operating cash flow for fiscal 2025 was $1.1B, up 28.9% from $837.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.1B. Over the past ten years it has ranged from $392.0M (fiscal 2022) to $1.1B (fiscal 2018); the current reading is higher than 82% of that period. Operating cash flow has risen for 3 consecutive fiscal years. Illumina, Inc. ranks 8th of 52 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.1B | 28.91% |
| FY2024 | $837.0M | 75.10% |
| FY2023 | $478.0M | 21.94% |
| FY2022 | $392.0M | (28.07%) |
| FY2021 | $545.0M | (49.54%) |
| FY2020 | $1.1B | 2.76% |
| FY2019 | $1.1B | (7.97%) |
| FY2018 | $1.1B | 30.51% |
| FY2017 | $875.0M | 12.32% |
| FY2016 | $779.0M | (0.89%) |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $201.0M | (30.45%) |
| Mar 2026 | $289.0M | (9.97%) |
| Dec 2025 | $321.0M | 13.03% |
| Sep 2025 | $284.0M | 21.37% |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| IQV IQVIA Holdings Inc. compare | $2.8B |
| DGX Quest Diagnostics Incorporated compare | $1.9B |
| LH Labcorp Holdings Inc. compare | $1.6B |
| A Agilent Technologies, Inc. compare | $1.6B |
| IDXX IDEXX Laboratories, Inc. compare | $1.4B |
| ILMN Illumina, Inc. | $1.1B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| WAT Waters Corporation compare | $549.6M |
| NTRA Natera, Inc. compare | $228.2M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on ILMN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement